Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Verhoeven

Showing results (11-20 of 147) with videos related to

Pageof 15
Sort By:
Expert Review of Clinical Immunology|January 24, 2017
Calprotectin and spondyloarthritisDaniel Wendling, Frank Verhoeven, Clément Prati
Joint Bone Spine|April 10, 2021
Dual Energy CT scan of erosive disk disease: The calcium resorption hypothesisThomas Leriche, Daniel Wendling, Frank Verhoeven
Expert Opinion on Biological Therapy|December 1, 2018
Anti-IL-17 monoclonal antibodies for the treatment of ankylosing spondylitisDaniel Wendling, Frank Verhoeven, Clément Prati
Rheumatology (Oxford, England)|October 20, 2019
Paradoxical Löfgren's syndrome in a patient treated with rituximab: interferon is not the keyOlivier Fakih, Frank Verhoeven, Clément Prati, et al.
Joint Bone Spine|October 14, 2021
Differences in distribution by department of prevalence and incidence of spondyloarthritis and inflammatory bowel diseases declared to the French National Health Insurance and their evolution between 2008 and 2018Olivier Fakih, Clément Prati, Daniel Wendling, et al.
Joint Bone Spine|July 4, 2018
Costovertebral arthritis revealing spondyloarthritisDaniel Wendling, Sébastien Aubry, Frank Verhoeven, et al.
Joint Bone Spine|February 17, 2020
Unilateral "sacro iliitis"?Daniel Wendling, Mickael Chouk, Frank Verhoeven, et al.
Joint Bone Spine|January 21, 2020
Cardiovascular risk in psoriatic arthritis, a narrative reviewFrank Verhoeven, Clément Prati, Céline Demougeot, et al.
Joint Bone Spine|July 3, 2025
Residual disease in axial spondyloarthritis. Facts and issuesDaniel Wendling, Philippe Goupille, Frank Verhoeven, et al.
Joint Bone Spine|January 28, 2015
Treatment of pseudo Felty's syndrome: Is there a place for rituximab?Frank Verhoeven, Xavier Guillot, Clément Prati, et al.
Pageof 15

Showing results (11-20 of 147) with videos related to

Sort By:
Pageof 15
Expert Review of Clinical Immunology|January 24, 2017
Calprotectin and spondyloarthritisDaniel Wendling, Frank Verhoeven, Clément Prati
Joint Bone Spine|April 10, 2021
Dual Energy CT scan of erosive disk disease: The calcium resorption hypothesisThomas Leriche, Daniel Wendling, Frank Verhoeven
Expert Opinion on Biological Therapy|December 1, 2018
Anti-IL-17 monoclonal antibodies for the treatment of ankylosing spondylitisDaniel Wendling, Frank Verhoeven, Clément Prati
Rheumatology (Oxford, England)|October 20, 2019
Paradoxical Löfgren's syndrome in a patient treated with rituximab: interferon is not the keyOlivier Fakih, Frank Verhoeven, Clément Prati, et al.
Joint Bone Spine|October 14, 2021
Differences in distribution by department of prevalence and incidence of spondyloarthritis and inflammatory bowel diseases declared to the French National Health Insurance and their evolution between 2008 and 2018Olivier Fakih, Clément Prati, Daniel Wendling, et al.
Joint Bone Spine|July 4, 2018
Costovertebral arthritis revealing spondyloarthritisDaniel Wendling, Sébastien Aubry, Frank Verhoeven, et al.
Joint Bone Spine|February 17, 2020
Unilateral "sacro iliitis"?Daniel Wendling, Mickael Chouk, Frank Verhoeven, et al.
Joint Bone Spine|January 21, 2020
Cardiovascular risk in psoriatic arthritis, a narrative reviewFrank Verhoeven, Clément Prati, Céline Demougeot, et al.
Joint Bone Spine|July 3, 2025
Residual disease in axial spondyloarthritis. Facts and issuesDaniel Wendling, Philippe Goupille, Frank Verhoeven, et al.
Joint Bone Spine|January 28, 2015
Treatment of pseudo Felty's syndrome: Is there a place for rituximab?Frank Verhoeven, Xavier Guillot, Clément Prati, et al.
Pageof 15